In contrast to previously characterized phosphorylation sites (S2030, S2808, and S2814) on RyR2, S2367 phosphorylation inhibits diastolic Ca2+-release from RyR2 while loss of phosphorylation of this site increases atrial fibrillation susceptibility. The gene discussed is RYR2; the disease is atrial fibrillation.